Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

168 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
NAT2 phenotype alters pharmacokinetics of rivaroxaban in healthy volunteers.
Villapalos-García G, Zubiaur P, Ochoa D, Soria-Chacartegui P, Navares-Gómez M, Matas M, Mejía-Abril G, Casajús-Rey A, Campodónico D, Román M, Martín-Vílchez S, Candau-Ramos C, Aldama-Martín M, Abad-Santos F. Villapalos-García G, et al. Among authors: matas m. Biomed Pharmacother. 2023 Sep;165:115058. doi: 10.1016/j.biopha.2023.115058. Epub 2023 Jun 28. Biomed Pharmacother. 2023. PMID: 37385211 Free article.
Association between CYP2C19 and CYP2B6 phenotypes and the pharmacokinetics and safety of diazepam.
Zubiaur P, Figueiredo-Tor L, Villapalos-García G, Soria-Chacartegui P, Navares-Gómez M, Novalbos J, Matas M, Calleja S, Mejía-Abril G, Román M, Ochoa D, Abad-Santos F. Zubiaur P, et al. Among authors: matas m. Biomed Pharmacother. 2022 Nov;155:113747. doi: 10.1016/j.biopha.2022.113747. Epub 2022 Sep 24. Biomed Pharmacother. 2022. PMID: 36162369 Free article.
Polymorphism of Drug Transporters, Rather Than Metabolizing Enzymes, Conditions the Pharmacokinetics of Rasagiline.
Zubiaur P, Matas M, Martín-Vílchez S, Soria-Chacartegui P, Villapalos-García G, Figueiredo-Tor L, Calleja S, Navares-Gómez M, de Miguel A, Novalbos J, Mejía-Abril G, Luquero-Bueno S, Román M, Ochoa D, Abad-Santos F. Zubiaur P, et al. Among authors: matas m. Pharmaceutics. 2022 Sep 21;14(10):2001. doi: 10.3390/pharmaceutics14102001. Pharmaceutics. 2022. PMID: 36297437 Free PMC article.
Genetic Variation in CYP2D6 and SLC22A1 Affects Amlodipine Pharmacokinetics and Safety.
Soria-Chacartegui P, Zubiaur P, Ochoa D, Villapalos-García G, Román M, Matas M, Figueiredo-Tor L, Mejía-Abril G, Calleja S, de Miguel A, Navares-Gómez M, Martín-Vilchez S, Abad-Santos F. Soria-Chacartegui P, et al. Among authors: matas m. Pharmaceutics. 2023 Jan 25;15(2):404. doi: 10.3390/pharmaceutics15020404. Pharmaceutics. 2023. PMID: 36839726 Free PMC article.
Concerns About a Dog Model of Dry Eye Disease.
Ofri R, Millichamp NJ, Keller C, McLellan GJ, Komáromy AM, Morton D, Matas M, Michau TM, Coall S, Sansom J, Leonard BC. Ofri R, et al. Among authors: matas m. Transl Vis Sci Technol. 2024 Mar 1;13(3):28. doi: 10.1167/tvst.13.3.28. Transl Vis Sci Technol. 2024. PMID: 38547120 Free PMC article. No abstract available.
Correction to: Domperidone nanocrystals with boosted oral bioavailability: fabrication, evaluation and molecular insight into the polymer-domperidone nanocrystal interaction.
Ndlovu ST, Ullah N, Khan S, Ramharack P, Soliman M, de Matas M, Shahid M, Sohail M, Imran M, Shah SWA, Hussain Z. Ndlovu ST, et al. Among authors: de matas m. Drug Deliv Transl Res. 2024 Apr;14(4):1108-1109. doi: 10.1007/s13346-024-01554-5. Drug Deliv Transl Res. 2024. PMID: 38416387 No abstract available.
Efficacy and adverse events profile of videolaryngoscopy in critically ill patients: subanalysis of the INTUBE study.
Russotto V, Lascarrou JB, Tassistro E, Parotto M, Antolini L, Bauer P, Szułdrzyński K, Camporota L, Putensen C, Pelosi P, Sorbello M, Higgs A, Greif R, Grasselli G, Valsecchi MG, Fumagalli R, Foti G, Caironi P, Bellani G, Laffey JG, Myatra SN; INTUBE Study Investigators. Russotto V, et al. Br J Anaesth. 2023 Sep;131(3):607-616. doi: 10.1016/j.bja.2023.04.022. Epub 2023 May 17. Br J Anaesth. 2023. PMID: 37208282
Pandemic Phase-Adjusted Analysis of COVID-19 Outcomes Reveals Reduced Intrinsic Vulnerability and Substantial Vaccine Protection From Severe Acute Respiratory Syndrome Coronavirus 2 in Patients With Breast Cancer.
Tagliamento M, Gennari A, Lambertini M, Salazar R, Harbeck N, Del Mastro L, Aguilar-Company J, Bower M, Sharkey R, Dalla Pria A, Plaja A, Jackson A, Handford J, Sita-Lumsden A, Martinez-Vila C, Matas M, Miguel Rodriguez A, Vincenzi B, Tonini G, Bertuzzi A, Brunet J, Pedrazzoli P, D'Avanzo F, Biello F, Sinclair A, Lee AJX, Rossi S, Rizzo G, Mirallas O, Pimentel I, Iglesias M, Sanchez de Torre A, Guida A, Berardi R, Zambelli A, Tondini C, Filetti M, Mazzoni F, Mukherjee U, Diamantis N, Parisi A, Aujayeb A, Prat A, Libertini M, Grisanti S, Rossi M, Zoratto F, Generali D, Saura C, Lyman GH, Kuderer NM, Pinato DJ, Cortellini A. Tagliamento M, et al. Among authors: matas m. J Clin Oncol. 2023 May 20;41(15):2800-2814. doi: 10.1200/JCO.22.01667. Epub 2023 Jan 31. J Clin Oncol. 2023. PMID: 36720089 Free article.
Nomogram based on baseline clinicopathological characteristics for predicting bladder cancer-specific survival to neoadjuvant chemotherapy in muscle-invasive bladder cancer.
Font A, Domenech M, Buisan O, Lopez H, González A, Etxaniz O, Matas M, Elias X, Gomez M, Figols M, Horneros J, Pardo JC, Notario L, Ruiz de Porras V, Perez I, Areal J, Esteve A. Font A, et al. Among authors: matas m. World J Urol. 2022 Nov;40(11):2627-2634. doi: 10.1007/s00345-022-04147-4. Epub 2022 Sep 15. World J Urol. 2022. PMID: 36107212
168 results